[The effect of a beta-adrenergic blocking agent on driving capability (author's transl)].
The effect of Betadrenol, a beta-adrenergic blocking agent, was studied by means of traffic psychology tests in 29 male patients with cardiovascular disorders. The age range was 29 to 60 years. After a 7-day wash-out period, each subject received either 3 x 100 mg Betadrenol or a placebo daily during three days. Subsequently every patient was given 3 x 100 mg of Betadrenol daily during another ten days. The short-term double-blind study revealed no impairment of driving performance. The results of the open study showed significant improvements, especially in concentration and speed of reaction.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001334:Automobile Driving; D002318:Cardiovascular Diseases / Q000188:drug therapy; D002319:Cardiovascular System / Q000187:drug effects; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D010465:Perception / Q000187:drug effects*; D010919:Placebos; D011581:Psychological Tests
D000319:Adrenergic beta-Antagonists; D010919:Placebos
Die Auswirkungen eines Beta-Rezeptorenblockers auf die Kraftfahreignung.